Chronic low-level exposure often presents as a confusing cluster of symptoms that standard medical testing cannot explain
If pregnancy is achieved, your doctor may recommend discontinuing semaglutide entirely, as it is typically not advised for use during pregnancy
GLP-1 therapy is not a standalone solution and is used as part of a comprehensive medical weight loss program
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV
To achieve this, its essential to focus on medication adherence
1 Introduction Obesity is a major global public health issue, defined as excessive adiposity that adversely affects health and is typically evaluated using body mass index (BMI 30 kg/m 2 ) ( Obesity increases the risk of chronic conditions and is associated with reduced life expectancy, increased all-cause mortality, and diminished health-related quality of life (HRQoL) ( Lifestyle modification, including diet, physical activity, and behavioral therapy, is the cornerstone of obesity management ( In Greece, liraglutide 3.0 mg is currently the only reimbursed pharmacotherapy for obesity